Joel M. Kremer
Joel M. Kremer publishes mostly in Rheumatology, Hematology and Immunology, on topics such as Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments and Autoimmune and Inflammatory Disorders Research.
- World rank
- #45,250 of 7,710,434 ranked researchers
- Rank in United States
- #17,421 of 1,627,098
- Works
- 451
- Citations
- 40k
- Citations per work
- 88.4
What does Joel M. Kremer research?
Joel M. Kremer's work is mostly in Medicine (66%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences29765.9%
- Medicine29765.9%
- Everything else12527.7%
- Life Sciences296.4%
- 1Rheumatology44% of their works
- 2Hematology9% of their works
- 3Immunology6% of their works
- 4Genetics6% of their works
- 5Pathology and Forensic Medicine4% of their works
- 6Public Health, Environmental and Occupational Health4% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
- Autoimmune and Inflammatory Disorders Research
- Systemic Lupus Erythematosus Research
- Chronic Lymphocytic Leukemia Research
- Biosimilars and Bioanalytical Methods
- Lymphoma Diagnosis and Treatment
- Acute Lymphoblastic Leukemia research
Which keywords describe Joel M. Kremer's research?
The keywords of their largest research topics: Autoantibodies, Inflammation, Rheumatoid Arthritis, Ankylosing Spondylitis, Rituximab, Spondyloarthritis, Hemophagocytic Lymphohistiocytosis and Juvenile Idiopathic Arthritis.
- Acute Lymphoblastic Leukemia
- Classification
- Biosimilars
- Chronic Lymphocytic Leukemia
- Antiphospholipid Syndrome
- Juvenile Idiopathic Arthritis
- Spondyloarthritis
- Ankylosing Spondylitis
- Inflammation
- Autoantibodies
- Rheumatoid Arthritis
- Rituximab
- Hemophagocytic Lymphohistiocytosis
- Prognostic Factors
- Systemic Lupus Erythematosus
- Genomic Aberrations
- Immunogenicity
- Lymphoma
- Childhood Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Autoantibodies4282 topics
- Inflammation3561 topic
- Rheumatoid Arthritis3561 topic
- Ankylosing Spondylitis1041 topic
- Rituximab1042 topics
- Spondyloarthritis1041 topic
- Hemophagocytic Lymphohistiocytosis1001 topic
- Juvenile Idiopathic Arthritis1001 topic
- Prognostic Factors942 topics
- Antiphospholipid Syndrome721 topic
- Systemic Lupus Erythematosus721 topic
- Chronic Lymphocytic Leukemia671 topic
- Genomic Aberrations671 topic
- Biosimilars461 topic
- Immunogenicity461 topic
- Classification371 topic
- Lymphoma371 topic
- Acute Lymphoblastic Leukemia271 topic
- Childhood Cancer271 topic
Where does Joel M. Kremer work?
Joel M. Kremer's main affiliation in the publication record is Albany Medical Center Hospital, United States.
How many publications and citations does Joel M. Kremer have?
OpenAlex counts 451 works and 39,862 citations for Joel M. Kremer, an h-index of 93, ranking #45,250 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Joel M. Kremer. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.